NCT05770037 DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers Status RECRUITING Phase PHASE2/PHASE3
NCT05755295 Horse Therapy for Children, Adolescents and Young Adults in Remission From Medulloblastoma Status RECRUITING Phase NA
NCT05701306 APG-115 Alone or in Combination With APG-2575 in Children With Recurrent or Refractory Neuroblastoma or Solid Tumors Status RECRUITING Phase PHASE1
NCT05489887 Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma Status RECRUITING Phase PHASE2
NCT05429502 Study of Efficacy and Safety of Ribociclib (LEE011) in Combination With Topotecan and Temozolomide (TOTEM) in Pediatric Patients With Relapsed or Refractory Neuroblastoma and Other Solid Tumors Status TERMINATED Phase PHASE1
NCT05421897 Rapid Administration Pilot for Infusing Dinutuximab Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05400603 Allogeneic Expanded Gamma Delta T Cells With GD2 Chemoimmunotherapy in Relapsed /Refractory Neuroblastoma or Refractory/ Relapsed Osteosarcoma Status RECRUITING Phase PHASE1
NCT05303727 Allogeneic Hematopoietic Stem Cell Transplantation for 4/M Neuroblastoma Status NOT_YET_RECRUITING Phase PHASE2
NCT05302921 Neoadjuvant Dual Checkpoint Inhibition and Cryoablation in Relapsed/Refractory Pediatric Solid Tumors Status COMPLETED Phase PHASE2
NCT05245123 Psychosocial Situation of Children With Rare Solid Abdominal Tumors and Their Families Status COMPLETED Phase N/A
NCT05192980 SIOPEN BIOPORTAL, An International Registry Linked to a Virtual Biobank for Patients With Peripheral Neuroblastic Tumours Status RECRUITING Phase NA
NCT05179850 Computer Aided Diagnostic Tool on Computed Tomography Images for Diagnosis of Retroperitoneal Tumor in Children Status UNKNOWN Phase N/A
NCT05135975 A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors Status RECRUITING Phase PHASE2
NCT05069220 18F-MFBG PET/CT in the Evaluation of Neural Crest Tumor Status RECRUITING Phase EARLY_PHASE1
NCT05027386 Apatinib Mesylate Combined With IT Regimen for the Treatment of Recurrent or Refractory Pediatric Neuroblastoma: A Single-arm, Phase I/II,Multi-center, Clinical Study. Status RECRUITING Phase PHASE1/PHASE2
NCT04947501 A Study of N9 Chemotherapy in Children With Neuroblastoma Status ACTIVE_NOT_RECRUITING Phase EARLY_PHASE1
NCT04936529 A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma Status RECRUITING Phase PHASE2
NCT04909515 Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GMCSF) and Isotretinoin for Consolidation of Patients With High-Risk Neuroblastoma in First Remission. Status WITHDRAWN Phase PHASE2
NCT04903899 177Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-risk Neuroblastoma Status RECRUITING Phase PHASE2
NCT04897321 B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR) Status RECRUITING Phase PHASE1